These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 12396230

  • 1. Long-term growth hormone replacement therapy in hypopituitary adults.
    Verhelst J, Abs R.
    Drugs; 2002; 62(16):2399-412. PubMed ID: 12396230
    [Abstract] [Full Text] [Related]

  • 2. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
    Chrisoulidou A, Beshyah SA, Rutherford O, Spinks TJ, Mayet J, Kyd P, Anyaoku V, Haida A, Ariff B, Murphy M, Thomas E, Robinson S, Foale R, Johnston DG.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
    [Abstract] [Full Text] [Related]

  • 3. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
    Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R, Johnston DG.
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [Abstract] [Full Text] [Related]

  • 5. The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement.
    Christ ER, Carroll PV, Russell-Jones DL, Sönksen PH.
    Schweiz Med Wochenschr; 1997 Aug 30; 127(35):1440-9. PubMed ID: 9297747
    [Abstract] [Full Text] [Related]

  • 6. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
    Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Góth MI, Wilton P, Koltowska-Häggström M.
    Eur J Endocrinol; 2006 Jul 30; 155(1):79-90. PubMed ID: 16793953
    [Abstract] [Full Text] [Related]

  • 7. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
    Gómez JM, Sahún M, Vila R, Domènech P, Catalina P, Soler J, Badimón L.
    Clin Endocrinol (Oxf); 2006 Jun 30; 64(6):632-9. PubMed ID: 16712664
    [Abstract] [Full Text] [Related]

  • 8. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.
    Abs R, Bengtsson BA, Hernberg-Stâhl E, Monson JP, Tauber JP, Wilton P, Wüster C.
    Clin Endocrinol (Oxf); 1999 Jun 30; 50(6):703-13. PubMed ID: 10468941
    [Abstract] [Full Text] [Related]

  • 9. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
    Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA.
    Clin Endocrinol (Oxf); 1997 Oct 30; 47(4):439-46. PubMed ID: 9404442
    [Abstract] [Full Text] [Related]

  • 10. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
    Franco C, Johannsson G, Bengtsson BA, Svensson J.
    J Clin Endocrinol Metab; 2006 Nov 30; 91(11):4408-14. PubMed ID: 16940452
    [Abstract] [Full Text] [Related]

  • 11. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U, Wilton P, Jonsson P, KIMS Study Group, KIMS International Board.
    Growth Horm IGF Res; 2004 Jun 30; 14 Suppl A():S51-8. PubMed ID: 15135778
    [Abstract] [Full Text] [Related]

  • 12. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.
    Götherström G, Bengtsson BA, Sunnerhagen KS, Johannsson G, Svensson J.
    Clin Endocrinol (Oxf); 2005 Jan 30; 62(1):105-13. PubMed ID: 15638878
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
    Monson JP, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stâhl E, Thorén M, Westberg B, Wilton P, Wüster C.
    Clin Endocrinol (Oxf); 2000 Sep 30; 53(3):281-9. PubMed ID: 10971444
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. GH-replacement therapy in adults.
    Christiansen JS, Jørgensen JO, Pedersen SA, Müller J, Jørgensen J, Møller J, Heickendorf L, Skakkebaek NE.
    Horm Res; 1991 Sep 30; 36 Suppl 1():66-72. PubMed ID: 1806489
    [Abstract] [Full Text] [Related]

  • 16. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.
    Rodríguez-Arnao J, Jabbar A, Fulcher K, Besser GM, Ross RJ.
    Clin Endocrinol (Oxf); 1999 Jul 30; 51(1):53-60. PubMed ID: 10468965
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Growth hormone replacement therapy for growth hormone-deficient adults.
    Powrie J, Weissberger A, Sönksen P.
    Drugs; 1995 May 30; 49(5):656-63. PubMed ID: 7601008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.